WORBOYS PHILIP D 4
4 · Theravance Biopharma, Inc. · Filed Feb 7, 2019
Insider Transaction Report
Form 4
WORBOYS PHILIP D
SVP, Translational Science
Transactions
- Award
Ordinary Shares
2019-02-05+65,000→ 227,380 total - Award
Ordinary Shares
2019-02-05+47,250→ 274,630 total
Footnotes (1)
- [F1]On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 5, 2019, the performance conditions applicable to 47,250 shares were achieved and such shares will vest on February 20, 2020, subject to the reporting person's continued service.